2006
DOI: 10.1186/cc4985
|View full text |Cite
|
Sign up to set email alerts
|

Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure

Abstract: Introduction Patients with acute-on-chronic liver failure show an aggravated hyperdynamic circulation. We evaluated, in a controlled manner, potential changes in systemic haemodynamics induced by the molecular adsorbent recirculating system (MARS) and the Prometheus system liver detoxification devices in a group of patients with acute-onchronic liver failure.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
24
1
1

Year Published

2007
2007
2021
2021

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 225 publications
(32 citation statements)
references
References 51 publications
0
24
1
1
Order By: Relevance
“…Circumstances that call for an immediate treatment with renal replacement therapy, such as severe hyperkalemia, metabolic acidosis, and volume overload are infrequent in patients with type 1 HRS, particularly in the early stages. There are isolated reports and a small randomized study suggesting that the so-called artificial liver support systems, either the molecular adsorbents recirculating system (MARS) or Prometheus, may have beneficial effects in patients with type 1 HRS [224,225]. However, these approaches should still be considered investigational until more data are available.…”
Section: Renal Replacement Therapymentioning
confidence: 99%
“…Circumstances that call for an immediate treatment with renal replacement therapy, such as severe hyperkalemia, metabolic acidosis, and volume overload are infrequent in patients with type 1 HRS, particularly in the early stages. There are isolated reports and a small randomized study suggesting that the so-called artificial liver support systems, either the molecular adsorbents recirculating system (MARS) or Prometheus, may have beneficial effects in patients with type 1 HRS [224,225]. However, these approaches should still be considered investigational until more data are available.…”
Section: Renal Replacement Therapymentioning
confidence: 99%
“…69 Molecular Adsorbent Recirculating System (MARS) and single-pass albumin dialysis, both of which have shown benefit in acute and acuteon-chronic liver failure, have also been researched as potential therapeutic modalities in hypoxic hepatitis but with uncertain benefit. [70][71][72] To date, no liver-specific treatments have been proven to improve outcome. Furthermore, hypoxic hepatitis is not an indication for liver transplantation as the hepatic derangements are reversible with correction of the underlying disorder.…”
Section: Treatmentmentioning
confidence: 99%
“…Furthermore, many patients with cirrhosis have elevated ammonia levels without evidence for encephalopathy. Recent work demonstrated that HE is the interplay between ammonia, inflammatory responses and autoregulation of cerebral hemodynamics [40]. 84 such cirrhotics were studied by Briegel et al [41].…”
Section: Role Of Cytokines In Liver Complicationsmentioning
confidence: 99%